Abstract

The RpoN-RpoS regulatory pathway plays a central role in governing adaptive changes by B. burgdorferi when the pathogen shuttles between its tick vector and mammalian hosts. In general, transcriptional activation of bacterial RpoN (σ54)-dependent genes requires an enhancer binding protein. B. burgdorferi encodes the putative enhancer binding protein Rrp2. Previous studies have revealed that the expression of σ54-dependent rpoS was abolished in an rrp2 point mutant. However, direct evidence linking the production of Rrp2 in B. burgdorferi and the expression of rpoS has been lacking, primarily due to the inability to inactivate rrp2 via deletion or insertion mutagenesis. Herein we introduced a regulatable (IPTG-inducible) rrp2 expression shuttle plasmid into B. burgdorferi, and found that the controlled up-regulation of Rrp2 resulted in the induction of σ54-dependent rpoS expression. Moreover, we created an rrp2 conditional lethal mutant in virulent B. burgdorferi. By exploiting this conditional mutant, we were able to experimentally manipulate the temporal level of Rrp2 expression in B. burgdorferi, and examine its direct impact on activation of the RpoN-RpoS regulatory pathway. Our data revealed that the synthesis of RpoS was coincident with the IPTG-induced Rrp2 levels in B. burgdorferi. In addition, the synthesis of OspC, a lipoprotein required by B. burgdorferi to establish mammalian infection, was rescued in the rrp2 point mutant when RpoS production was restored, suggesting that Rrp2 influences ospC expression indirectly via its control over RpoS. These data demonstrate that Rrp2 is required for the synthesis of RpoS, presumably via its action as an enhancer binding protein for the activation of RpoN and subsequent transcription of rpoS in B. burgdorferi.

Highlights

  • Borrelia burgdorferi, the causative agent of Lyme disease, is sustained in nature via a complex life cycle involving an arthropod tick vector (Ixodes scapularis) and mammals [1,2]

  • Once RpoS is produced, it functions as a master regulator to modulate the expression of a number of virulence-associated outer membrane lipoproteins such as outer surface lipoproteins (Osp) C and A, and decorin binding proteins (Dbp) B and A [4,8,12,13,14,18,29,32,36,40,46,47,48,49,50,51,52,53,54,55,56,57]

  • We introduced a G239C mutation into rrp2 and created an rrp2 point mutant OY01 in B. burgdorferi [29]

Read more

Summary

Introduction

The causative agent of Lyme disease, is sustained in nature via a complex life cycle involving an arthropod tick vector (Ixodes scapularis) and mammals [1,2]. Among a number of potential regulators that have been postulated to be present in B. burgdorferi [10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45], a novel genetic regulatory pathway, the RpoN-RpoS pathway (or the s54-sS cascade) [18], plays a central role in modulating B. burgdorferi host adaptive responses and virulence expression. Once RpoS is produced, it functions as a master regulator to modulate the expression of a number of virulence-associated outer membrane lipoproteins such as outer surface lipoproteins (Osp) C and A, and decorin binding proteins (Dbp) B and A [4,8,12,13,14,18,29,32,36,40,46,47,48,49,50,51,52,53,54,55,56,57]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call